Lastly, additional mutations targeting major tumor suppressors such as P53 and BAX, anti-apoptotic factors such as BCL-2, pro-angiogenic factors, and extracellular matrix-degrading factors promote CRC cell motility, enabling invasion and metastatization of distant organs [6,73,74]. The gene discussed is BCL2; the disease is colorectal carcinoma.